Mobile Application Development Sample Clauses

Mobile Application Development. Getting the Tools You Need iOS Project Debugging iOS Apps Objective-C Basics Hello World App Building the Derby App in iOS Other Useful iOS Things Getting Started with Appcelerator Titanium Why use Titanium? Who is using Titanium? Getting the Tools You need Connecting Titanium to the markets Building the Derby App in Titanium Getting Started with PhoneGap History of PhoneGap Why Use PhoneGap? Who is using PhoneGap? Difference between PhoneGap and HTML5 Getting the Tools You Need PhoneGap Project Building the derby App in PhoneGap Other Useful Phone Gap Things Connecting PhoneGap to the Markets Getting Started with Monotouch and Mono for Android The Mono Framework Getting the Tools You Need Getting to know MonoDevelop Mono Project Building the Derby App with Mono Other Useful MonoTouch/Mono Features PhoneGap for Mobile Application: Movement and Location: Using the Accelerometer and Geolocation Introduction Detecting device movement using the accelerometer Adjusting the accelerometer sensor update interval Updating a display object position through accelerometer events Obtaining device geolocation sensor information Adjusting the geolocation sensor update interval Retrieving map data through geolocation coordinates Creating a visual compass to show the device direction File System, Storage, and Local Databases Introduction Saving a file to device storage Opening a local file from device storage Displaying the contents of a directory Creating a local SQLite database Uploading a file to a remote server Caching content using the web storage local storage API Working with Audio, Images, and Video Introduction Capturing audio using the devices audio recording application Recording audio within your application Playing audio files from the local filesystem or over HTTP Capturing video using the devices video recording application Loading a photograph from the devices camera roll/library Applying an effect to an image using canvas Working with Your Contacts Introduction Listing all available contacts Displaying contact information for a specific individual Creating and saving a new contact Hook into Native Events Introduction Pausing your application Resuming your application Displaying the status of the device battery levels Making use the native search button Displaying network connection status PhoneGap for Mobile Application Creating a custom submenu Working with XUI Introduction Learning the basics of the XUI library DOM manipulation Working with touch and ges...
AutoNDA by SimpleDocs
Mobile Application Development. Vuria will be integrating changes for both iPhone and Android mobile device platforms only (no native tablet app). Integrating new features in an application involves the following process;
Mobile Application Development 

Related to Mobile Application Development

  • Information Systems Acquisition Development and Maintenance Security of System Files. To protect City Information Processing Systems and system files containing information, Service Provider will ensure that access to source code is restricted to authorized users whose specific job function necessitates such access.

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Business Development Company Status The Company, during a period of at least 12 months from the Closing Time, will use its commercially reasonable efforts to maintain its status as a business development company; provided, however, the Company may cease to be, or withdraw its election as, a business development company, with the approval of the board of directors and a vote of stockholders as required by Section 58 of the 1940 Act or any successor provision.

  • Business Development Provide advice and assistance in business growth and development of Party B. 业务发展。对乙方的业务发展提供建议和协助。

  • Business Development Company Buyer is a business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Regulatory Affairs Development and production of medical products and processes fall under the purview of the Food and Drug Administration (FDA) and research on these products involving animal or human studies is regulated by other laws, directives, and regulations. Project Awards under this Agreement that involve work in support of or related to FDA regulatory approval will address contingencies for Government access to regulatory rights in the event of product development abandonment or failure. Efforts conducted under this OTA shall be done ethically and in accordance with all applicable laws, directives, and regulations. The Government shall ensure performance includes regulatory expertise and guidance for candidate medical countermeasure development efforts:

Time is Money Join Law Insider Premium to draft better contracts faster.